Evidence map›Paper›PMID 35885282›Full record

ArticleFoods (Basel, Switzerland)2022

Effect of Bergamot and Laoxianghuang Polysaccharides on Gut Microbiota Derived from Patients with Hyperlipidemia: An Integrative Analysis of Microbiome and Metabolome during In Vitro Fermentation.

Yang Zheng, Yi Wang, Donghui Luo, Lianzhu Lin, Xingyu Lu, Jie Gao, Chuqiao Xiao, Mouming Zhao

Open access · goldAbstract read
In one paragraph

Article in Foods (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Effects of fermentedFrontiers in pharmacology · 2024
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Yang ZhengChaozhou Branch of Chemistry and Chemical Engineering Guangdong Laboratory, Chaozhou 521000, China.
Yi WangJinhua Academy of Agricultural Sciences, Jinhua 321000, China.
Donghui LuoChaozhou Branch of Chemistry and Chemical Engineering Guangdong Laboratory, Chaozhou 521000, China.
Lianzhu LinChaozhou Branch of Chemistry and Chemical Engineering Guangdong Laboratory, Chaozhou 521000, China.
Xingyu LuSchool of Light Industry and Food Engineering, Guangxi University, Nanning 530004, China.
Jie GaoSchool of Light Industry and Food Engineering, Guangxi University, Nanning 530004, China.ORCID 0000-0003-4480-6420
Chuqiao XiaoChaozhou Branch of Chemistry and Chemical Engineering Guangdong Laboratory, Chaozhou 521000, China.ORCID 0000-0001-7474-1387
Mouming ZhaoSchool of Food Science and Engineering, South China University of Technology, Guangzhou 510640, China.
Chaozhou Central Hospital · CNGuangxi University · CNJinhua Academy of Agricultural Sciences · CNSouth China University of Technology · CN

Funding

Key-Area Research and Development Program of Guangdong Province 2021B0707060001National Natural Science Foundation of China 32001696Self-innovation Research Funding Project of Hanjiang Laboratory HJL202010B001Self-innovation Research Funding Project of Hanjiang Laboratory HJL202012A01
6 · The paper itself

Abstract

The aim of this study was to investigate the effects of bergamot polysaccharide (BP) and Laoxianghuang polysaccharides (LPs, fermented bergamot) on the microbiome and metabolome during the in vitro fermentation of gut microbiota from patients with hyperlipidemia. Results indicated that both BP and LPs were able to increase the production of acetic acid, propionic acid, and butyric acid. However, only LPs could decrease the content of isobutyric acid and isovaleric acid, which are detrimental to gut health. A 16S rRNA analysis showed that both BP and LPs could reduce the proportion of

Indexed as

gut microbiotahyperlipidemicmetabolomicspolysaccharideSCFAs

Identifiers

PMID35885282
PMCPMC9323038
OpenAlexW4285011424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.